• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Researchers develop better way to determine safe drug doses for children

Bioengineer by Bioengineer
May 6, 2021
in Science News
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New research on organ maturation models could lead to improvements in drug development

IMAGE

Credit: Image: Matti Ahlgren

Determining safe yet effective drug dosages for children is an ongoing challenge for pharmaceutical companies and medical doctors alike. A new drug is usually first tested on adults, and results from these trials are used to select doses for pediatric trials. The underlying assumption is typically that children are like adults, just smaller, which often holds true, but may also overlook differences that arise from the fact that children’s organs are still developing.

Compounding the problem, pediatric trials don’t always shed light on other differences that can affect recommendations for drug doses. There are many factors that limit children’s participation in drug trials – for instance, some diseases simply are rarer in children – and consequently, the generated datasets tend to be very sparse.

To make drugs and their development safer for children, researchers at Aalto University and the pharmaceutical company Novartis have developed a method that makes better use of available data.

‘This is a method that could help determine safe drug doses more quickly and with less observations than before,’ says co-author Aki Vehtari, an associate professor of computer science at Aalto University and the Finnish Center for Artificial Intelligence FCAI.

In their study, the research team created a model that improves our understanding of how organs develop.

‘The size of an organ is not necessarily the only thing that affects its performance. Kids’ organs are simply not as efficient as those of adults. In drug modeling, if we assume that size is the only thing that matters, we might end up giving too large of doses,’ explains Eero Siivola, first author of the study and doctoral student at Aalto University.

Whereas the standard approach of assessing pediatric data relies on subjective evaluations of model diagnostics, the new approach, based on Gaussian process regression, is more data-driven and consequently less prone to bias. It is also better at handling small sample sizes as uncertainties are accounted for.

The research comes out of FCAI’s research programme on Agile and probabilistic AI, offering a great example of a method that makes the best out of even very scarce datasets.

In the study, the researchers demonstrate their approach by re-analyzing a pediatric trial investigating Everolimus, a drug used to prevent the rejection of organ transplants. But the possible benefits of their method are far reaching.

‘It works for any drug whose concentration we want to examine,’ Vehtari says, like allergy and pain medication.

The approach could be particularly useful for situations where a new drug is tested on a completely new group — of children or adults — which is small in size, potentially making the trial phase much more efficient than it currently is. Another promising application relates to extending use of an existing drug to other symptoms or diseases; the method could support this process more effectively than current practices.

###

The paper will be published on May 10 in the journal Statistics in Medicine, already available online.

Media Contact
Doctoral Candidate Eero Siivola
[email protected]

Original Source

https://www.aalto.fi/en/news/researchers-develop-better-way-to-determine-safe-drug-doses-for-children

Related Journal Article

http://dx.doi.org/10.1002/sim.8907

Tags: Computer ScienceDiagnosticsInternal MedicineMedicine/HealthPharmaceutical ChemistryPharmaceutical ScienceResearch/DevelopmentRobotry/Artificial IntelligenceTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Revolutionizing Language Models with Analog In-Memory Computing

October 3, 2025

Scientists Analyze Chikungunya Outbreak Patterns to Enhance Prediction and Advance Vaccine Development

October 3, 2025

Enhancing Pediatric Palliative Care: VR for Provider Wellbeing

October 3, 2025

California Partnership Boosted COVID-19 Response and Advanced Health Equity, Report Reveals

October 3, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    93 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    88 shares
    Share 35 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    67 shares
    Share 27 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionizing Language Models with Analog In-Memory Computing

Scientists Analyze Chikungunya Outbreak Patterns to Enhance Prediction and Advance Vaccine Development

Enhancing Pediatric Palliative Care: VR for Provider Wellbeing

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.